We are live on ! Find out more
CA

Clearstead Advisors Portfolio holdings

AUM $10.9B
1-Year Est. Return 18.41%
This Fund
S&P 500
This Quarter Est. Return
-15.27%
1 Year Est. Return
+18.41%
3 Year Est. Return
+59.5%
5 Year Est. Return
+69.09%
10 Year Est. Return
AUM
$1.28B
AUM Growth
-$191M
Cap. Flow
+$52.5M
Cap. Flow %
4.09%
Top 10 Hldgs %
34.1%
Holding
1,516
New
99
Increased
402
Reduced
286
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 12.34%
2 Healthcare 8.16%
3 Financials 7.84%
4 Consumer Discretionary 5.22%
5 Consumer Staples 4.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
C icon
301
Citigroup
C
$222B
$327K 0.03%
7,108
-1,206
-15% -$60.3K
KR icon
302
Kroger
KR
$34.7B
$326K 0.03%
6,888
+137
+2% +$7.3K
COP icon
303
ConocoPhillips
COP
$146B
$321K 0.03%
3,573
+314
+10% +$32.4K
ZTS icon
304
Zoetis
ZTS
$31.7B
$320K 0.02%
1,864
+96
+5% +$16.6K
AMP icon
305
Ameriprise Financial
AMP
$46.5B
$319K 0.02%
1,343
ACWV icon
306
iShares MSCI Global Min Vol Factor ETF
ACWV
$3.26B
$317K 0.02%
3,351
+24
+0.7% +$2.38K
NOCT icon
307
Innovator Growth-100 Power Buffer ETF October
NOCT
$227M
$316K 0.02%
9,000
HZNP
308
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$314K 0.02%
3,937
+66
+2% +$6.25K
RELX icon
309
RELX
RELX
$59.9B
$312K 0.02%
11,573
DFAX icon
310
Dimensional World ex US Core Equity 2 ETF
DFAX
$11.8B
$310K 0.02%
14,444
+5
+0% +$116
KDP icon
311
Keurig Dr Pepper
KDP
$40.3B
$309K 0.02%
8,733
MCHP icon
312
Microchip Technology
MCHP
$43B
$309K 0.02%
5,327
-393
-7% -$26K
PLPC icon
313
Preformed Line Products
PLPC
$1.54B
$308K 0.02%
5,000
TDG icon
314
TransDigm Group
TDG
$69.3B
$308K 0.02%
573
CI icon
315
Cigna
CI
$76.1B
$306K 0.02%
1,161
BAX icon
316
Baxter International
BAX
$11.6B
$304K 0.02%
4,738
+22
+0.5% +$1.6K
ZION icon
317
Zions Bancorporation
ZION
$10.1B
$304K 0.02%
5,981
BMRN icon
318
BioMarin Pharmaceuticals
BMRN
$11.4B
$302K 0.02%
3,649
SCHD icon
319
Schwab US Dividend Equity ETF
SCHD
$102B
$300K 0.02%
12,576
-5,304
-30% -$135K
XYZ
320
Block Inc
XYZ
$46.2B
$300K 0.02%
4,882
+291
+6% +$26.6K
OTIS icon
321
Otis Worldwide
OTIS
$27.5B
$298K 0.02%
4,213
-199
-5% -$14.7K
BIIB icon
322
Biogen
BIIB
$29.9B
$296K 0.02%
1,453
BP icon
323
BP
BP
$113B
$294K 0.02%
10,381
+4,171
+67% +$128K
ARKG icon
324
ARK Genomic Revolution ETF
ARKG
$1.53B
$293K 0.02%
9,315
-1,333
-13% -$46.6K
RF icon
325
Regions Financial
RF
$26.3B
$292K 0.02%
15,582
-899
-5% -$18.6K

Similar funds

Clearstead Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Clearstead Advisors held 1,516 positions worth $1.28B, down 13% from $1.47B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Clearstead Advisors deployed $52.5M of net new capital in Q2 2022, opening 99 new positions and adding to 402 existing holdings. Its largest new stake was Bed Bath & Beyond Inc: 100,000 shares worth $497K.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was ProShares Ultra QQQ, an estimated $2.11M trimmed.

  • Clearstead Advisors's largest Q2 2022 buy was Bed Bath & Beyond Inc: 100,000 shares worth $497K.
  • Clearstead Advisors added most to JPMorgan Equity Premium Income ETF in Q2 2022, an estimated $14.8M increase.
  • Clearstead Advisors's biggest Q2 2022 reduction was ProShares Ultra QQQ, cutting an estimated $2.11M.
  • Clearstead Advisors fully exited Reinsurance Group of America in Q2 2022, selling an estimated $693K.
  • Clearstead Advisors's ten largest holdings make up 34% of its $1.28B portfolio in Q2 2022.
  • Clearstead Advisors opened 99 new positions and closed 180 in Q2 2022.
  • Clearstead Advisors's portfolio value fell 13% quarter-over-quarter to $1.28B.

Based on Clearstead Advisors's 13F filing for Q2 2022, filed 12 Aug 2022.